LanCL2 was mainly found in the nucleus and cytoplasm of high-grade glioma cells (grade III–IV), whereas it was expressed on the nuclear membrane of low-grade (grade I–II) glioma cells (Fig. 5A). The gene discussed is LANCL2; the disease is central nervous system cancer.